What are the implications of CAR in pharmacogenomics?
Variability in the expression and activity of CAR among individuals can influence their response to drugs and susceptibility to toxicants. Genetic polymorphisms in CAR-related genes may contribute to differences in drug metabolism rates, affecting both efficacy and toxicity. Pharmacogenomics research aims to personalize drug therapy by considering such genetic factors to optimize treatment outcomes.
